πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,022 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9556130

4-oxo-3,4-dihydro-1,2,3-benzotriazine modulators of GPR139

Takeda Pharmaceutical Company Limited Β· Granted Tue Jan 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9556200

Tricyclic compound

Takeda Pharmaceutical Company Limited Β· Granted Tue Jan 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9550756

Pyridazinone compounds as phosphodiesterase inhibitors and methods of treating disorders

Takeda Pharmaceutical Company Limited Β· Granted Tue Jan 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9533966

Cyclic compounds

Takeda Pharmaceutical Company Limited Β· Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9527841

Substituted pyrido[2,3-b]pyrazines as phosphodiesterase 2A inhibitors

Takeda Pharmaceutical Company Limited Β· Granted Tue Dec 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9527807

Sulfonamide derivative and use thereof

Takeda Pharmaceutical Company Limited Β· Granted Tue Dec 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9517210

Method for producing microcapsule powder

Takeda Pharmaceutical Company Limited Β· Granted Tue Dec 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9518042

Nitrogen-containing heterocyclic compound

Takeda Pharmaceutical Company Limited Β· Granted Tue Dec 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9512118

Crystal of fused heterocyclic compound

Takeda Pharmaceutical Company Limited Β· Granted Tue Dec 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9505772

Aromatic ring compound

Takeda Pharmaceutical Company Limited Β· Granted Tue Nov 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9499516

Nitrogen-containing heterocyclic compound

Takeda Pharmaceutical Company Limited Β· Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9499568

Heterocyclic compound and use thereof

Takeda Pharmaceutical Company Limited Β· Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9493432

Cyclopentylbenzamide derivatives and their use for the treatment of psychotic and cognitiv

Takeda Pharmaceutical Company Limited Β· Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9493484

Heterocyclic compound and use thereof

Takeda Pharmaceutical Company Limited Β· Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9486446

Orally disintegrating solid preparation

Takeda Pharmaceutical Company Limited Β· Granted Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9486411

Solid preparation

Takeda Pharmaceutical Company Limited Β· Granted Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9487485

Method for producing sulfonyl chloride compound

Takeda Pharmaceutical Company Limited Β· Granted Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9487509

Heterocyclic compound

Takeda Pharmaceutical Company Limited Β· Granted Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9487511

Cyclopropanamine compound and use thereof

Takeda Pharmaceutical Company Limited Β· Granted Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9487526

Quinoxaline derivatives as GPR6 modulators

Takeda Pharmaceutical Company Limited Β· Granted Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9475822

Substituted 2- amidoquinazol-4-ones as matrix metalloproteinase-13 inhibitors

Takeda Pharmaceutical Company Limited Β· Granted Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9475816

Substituted-1,4-dihydropyrazolo[4,3-b]indoles

Takeda Pharmaceutical Company Limited Β· Granted Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9475795

Sulfonyl piperidine derivatives and their use for treating prokineticin mediated diseases

Takeda Pharmaceutical Company Limited Β· Granted Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9469637

Nitrogenated heterocyclic compound

Takeda Pharmaceutical Company Limited Β· Granted Tue Oct 18 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 13 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted